Abstract
Encephalitis refers to an acute, usually diffuse, inflammatory process affecting the brain. The clinical hallmark of acute encephalitis is the triad of fever, headache, and altered mental status. The most common and important cause of encephalitis is the infection by a virus although other organisms can cause the disease. This article is a general overview of the most common viral encephalitides, divided into two families, Flavivirus and Alphavirus, and provides details about virus and RNA interference. More detailed descriptions of each viral family are provided bellow.
Keywords: Virus, encephalitis, flavivirus, alphavirus, RNAinterference, inflammatory disease, neurological examinations, single-stranded RNA
Central Nervous System Agents in Medicinal Chemistry
Title: Arboviral Encephalitis and RNAi Treatment
Volume: 11 Issue: 4
Author(s): Mauricio L. Nogueira, Mara Correa Lelles Nogueira and Carolina Pacca
Affiliation:
Keywords: Virus, encephalitis, flavivirus, alphavirus, RNAinterference, inflammatory disease, neurological examinations, single-stranded RNA
Abstract: Encephalitis refers to an acute, usually diffuse, inflammatory process affecting the brain. The clinical hallmark of acute encephalitis is the triad of fever, headache, and altered mental status. The most common and important cause of encephalitis is the infection by a virus although other organisms can cause the disease. This article is a general overview of the most common viral encephalitides, divided into two families, Flavivirus and Alphavirus, and provides details about virus and RNA interference. More detailed descriptions of each viral family are provided bellow.
Export Options
About this article
Cite this article as:
L. Nogueira Mauricio, Correa Lelles Nogueira Mara and Pacca Carolina, Arboviral Encephalitis and RNAi Treatment, Central Nervous System Agents in Medicinal Chemistry 2011; 11 (4) . https://dx.doi.org/10.2174/1871524911106040296
DOI https://dx.doi.org/10.2174/1871524911106040296 |
Print ISSN 1871-5249 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6166 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Herpes Simplex Virus Vectors for Gene Delivery to a Variety of Different Cell Types
Current Gene Therapy Isoform-Selective PI3K Inhibitors for Various Diseases
Current Topics in Medicinal Chemistry Progressive Supranuclear Palsy: What Do We Know About it?
Current Medicinal Chemistry Defining and Regulating Acute Inflammatory Lesion Formation during the Pathogenesis of Multiple Sclerosis and Experimental Autoimmune Encephalomyelitis
CNS & Neurological Disorders - Drug Targets Viral Myocarditis and Dilated Cardiomyopathy: Etiology and Pathogenesis
Current Pharmaceutical Design Baculovirus as Vaccine Vectors
Current Gene Therapy Nano-formulations for Diagnostics and Therapeutics of Foot-and-Mouth Disease in Animals
Nanoscience & Nanotechnology-Asia First-in-Human Study of the Safety, Tolerability, Pharmacokinetics and - Preliminary Dynamics of Neuroprotectant 2-Iminobiotin in Healthy Subjects
Current Clinical Pharmacology Drug Targets from Genetics: Alpha-Synuclein
CNS & Neurological Disorders - Drug Targets FMRI of the Emotions: Towards an Improved Understanding of Amygdala Function
Current Medical Imaging West Nile Virus NS2B/NS3 Protease As An Antiviral Target
Current Medicinal Chemistry Small Molecule Antagonists of the Chemokine Receptor CCR5
Current Topics in Medicinal Chemistry Guinea Pig Model of Infectious Disease - Viral Infections
Current Drug Targets Immune Therapy for Infectious Diseases at the Dawn of the 21st Century: the Past, Present and Future Role of Antibody Therapy, Therapeutic Vaccination and Biological Response Modifiers
Current Pharmaceutical Design Recent Advancements in Nanodiamond Mediated Brain Targeted Drug Delivery and Bioimaging of Brain Ailments: A Holistic Review
Pharmaceutical Nanotechnology Potential Use of Nanomedicine for Drug Delivery Across the Blood-Brain Barrier in Healthy and Diseased Brain
CNS & Neurological Disorders - Drug Targets Meet Our Editorial Board Member
Clinical Cancer Drugs Control of Autoimmune Diseases by the B7-CD28 Family Molecules
Current Pharmaceutical Design Cannabinoids and Neurodegenerative Diseases
CNS & Neurological Disorders - Drug Targets New Perspectives in HCV Therapy: Entry Inhibitors
Recent Patents on Anti-Infective Drug Discovery